Breaking Through the Blockades
- Biosimilars landscape and new trends. Understanding long-term strategies in evolving regulatory environment
-
Impact of current pandemic situation in FDA approvals and clinical trials
-
Current challenges in developing and supplying biosimilars globally
-
Advancing biosimilars developments through affordable innovations and advancing technologies
-
Updates on chemical and analytical techniques for developing biosimilars